Hansoh Pharmaceutical Group Dividenden en inkoop
Dividend criteriumcontroles 2/6
Hansoh Pharmaceutical Group is een dividendbetalend bedrijf met een huidig rendement van 2.09% dat ruimschoots wordt gedekt door de winst.
Belangrijke informatie
2.1%
Dividendrendement
0.04%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 2.1% |
| Toekomstig dividendrendement | 1.1% |
| Dividendgroei | 53.0% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | HK$0.402 |
| Uitbetalingsratio | 40% |
Recente updates van dividend en inkoop
Recent updates
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Hoewel de dividendbetalingen stabiel zijn, betaalt 3692 nog geen 10 jaar dividend uit.
Groeiend dividend: De dividendbetalingen van 3692 zijn gestegen, maar het bedrijf heeft pas 4 jaar dividend uitgekeerd.
Dividendrendement versus markt
| Hansoh Pharmaceutical Group Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (3692) | 2.1% |
| Markt onderkant 25% (HK) | 3.3% |
| Markt Top 25% (HK) | 8.1% |
| Gemiddelde industrie (Pharmaceuticals) | 3.8% |
| Analist prognose (3692) (tot 3 jaar) | 1.1% |
Opmerkelijk dividend: Het dividend van 3692 ( 2.09% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de Hong Kong markt ( 3.3% ).
Hoog dividend: Het dividend 3692 ( 2.09% ) is laag vergeleken met de top 25% van dividendbetalers in de Hong Kong markt ( 8.06% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn redelijk lage payout ratio ( 39.6% ) worden de dividendbetalingen van 3692 ruimschoots gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn redelijke cash payout ratio ( 52% ) worden de dividendbetalingen van 3692 gedekt door kasstromen.